DOW JONES22,117.95+481.17 2.22%
S&P 5002,607.43+65.96 2.60%
NASDAQ7,719.64+217.27 2.90%

Urovant Sciences Receives U.S. FDA Acceptance Of New Drug Application For Vibegron For The Treatment Of Overactive Bladder

Benzinga · 03/05/2020 13:09